Radiation-therapy vendor Nucletron received FDA clearance to market the newest iterations of its stereotactic planning software and multimodality image fusion software for radiation therapy planning.
The company’s radiosurgery planning software (SRS) provides treatment planning for stereotactic radiosurgery, widely used for the treatment of small brain lesions. The new version has an automatic optimization feature that reduces the time needed to achieve a radiation dose distribution. In addition, the SRS is head-frame independent, the company said.
Nucletron’s image fusion software (IFS) is able to correlate images from different imaging modalities. The correlation methods include the use of user-defined reference points, a stereotactic frame, or manual adjustments of overlaid images. Image fusion allows image sets to be correlated and the target volume transferred to CT images for planning radiation therapy treatments.
The Veenendaal, Netherlands-based firm hopes to place IFS in institutions using intensity modulated radiation therapy (IMRT), as well as at clinics using both brachytherapy and external beam radiation therapy. Both products are available as stand-alone components or as part of a radiotherapy treatment-planning suite called Plato.
By AuntMinnie.com staff writersMay 21, 2001
Related Reading
Delft takes majority stake in Rogan, January 4, 2001
Nucletron unveils digital chest unit, November 28, 2000
Use of high-dose-rate afterloading brachytherapy in prostate cancer is rising, November 27, 2000
Nucletron announces first U.S. user of Advanced Simulation, August 30, 2000
FDA clears Nucletron's SPOT imaging software for prostate seed implantation, August 8, 2000
Copyright © 2001 AuntMinnie.com
